What Are the Key Growth Drivers for APIs in the Blood Cancer Segment, and How Are They Impacting Market Share? The Active Pharmaceutical Ingredient (API) market for blood cancer has been experiencing significant growth, driven primarily by advancements in targeted therapies and immuno-oncology. Key players like AbbVie and Johnson & Johnson have been at the forefront,...